Serum S100B protein is specifically related to white matter changes in Schizophrenia

Frontiers in Cellular Neuroscience

Volumn 10, Issue MAR2016, 2016, Pages

  Milleit, Berko ^a,b   Smesny, Stefan ^a   Rothermundt, Matthias ^c,d   Preul, Christoph ^a   Schroeter, Matthias L ^e   Von Eiff, Christof ^c,h   Ponath, Gerald ^c,f   Milleit, Christine ^a,g   Sauer, Heinrich ^a   Gaser, Christian ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b ST JOSEPH KRANKENHAUS   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d St Rochus Hospital   (Germany)

^e MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Sophien und Hufeland Klinikum Weimar   (Germany)

^h Pizer Pharma GmbH   (Germany)

Author keywords

First episode psychosis; S100B; Schizophrenia; VBM; Voxel based morphometry; White matter

Indexed keywords

PROTEIN S100B;

ADULT; ARTICLE; BLOOD SAMPLING; CINGULUM (BRAIN); CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST ACUTE PSYCHOTIC EPISODE; GRAY MATTER; HUMAN; INFERIOR LONGITUDINAL FASCICULUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; RECURRENT ACUTE PSYCHOTIC EPISODE; SCHIZOPHRENIA; SUPERIOR TEMPORAL GYRUS; VOXEL BASED MORPHOMETRY; WHITE MATTER;

EID: 84961696382     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2016.00033     Document Type: Article

References (72)

1. Ahlemeyer, B. Beier, H. Semkova, I. Schaper, C. and Krieglstein, J. (2000). S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)- receptor agonist, Bay x 3702. Brain Res. 858, 121-128. doi:10.1016/S0006- 8993(99)02438-5
2. Aleksovska, K. Leoncini, E. Bonassi, S. Cesario, A. Boccia, S. and Frustaci, A. (2014). Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia. PLoS ONE 9:e106342. doi:10.1371/journal.pone.0106342
3. Andreasen, N. C. Paradiso, S. and O’Leary, D. S. (1998). "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr. Bull. 24, 203-218.
4. Ashburner, J. and Friston, K. J. (2000). Voxel-based morphometry-the methods. Neuroimage 11, 805-821. doi: 10.1006/nimg.2000.0582
5. Ashtari, M. Cottone, J. Ardekani, B. A. Cervellione, K. Szeszko, P. R. Wu, J. et al. (2007). Disruption of white matter integrity in the inferior longitudinal fasciculus in adolescents with schizophrenia as revealed by fiber tractography. Arch. Gen. Psychiatry 64, 1270-1280. doi: 10.1001/archpsyc.64.11.1270
6. Begré, S. and Koenig, T. (2008). Cerebral disconnectivity: an early event in schizophrenia. Neuroscientist 14, 19-45. doi: 10.1177/1073858406298391
7. Bogerts, B. Ashtari, M. Degreef, G. Alvir, J. M. Bilder, R. M. and Lieberman,J. A. (1990). Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res. 35, 1-13. doi:10.1016/0925-4927(90)90004-P
8. Brans, R. G. H. van Haren, N. E. M. van Baal, G. C. M. Staal, W. G. Schnack, H. G. Kahn, R. S. et al. (2008). Longitudinal MRI study in schizophrenia patients and their healthy siblings. Br. J. Psychiatry 193, 422-423. doi: 10.1192/bjp.bp.107.041467
9. Cuadra, M. B. Cammoun, L. Butz, T. Cuisenaire, O. and Thiran, J. P. (2005). Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Trans. Med. Imaging 24, 1548-1565. doi: 10.1109/TMI.2005.857652
10. Davis, K. L. Stewart, D. G. Friedman, J. I. Buchsbaum, M. Harvey, P. D. Hof, P. R. et al. (2003). White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 60, 443-456. doi: 10.1001/archpsyc.60.5.443
11. DeLisi, L. E. (1999). Regional brain volume change over the life-time course of schizophrenia. J. Psychiatr. Res. 33, 535-541. doi: 10.1016/S0022-3956(99)00028-X
12. DeLisi, L. E. and Hoff, A. L. (2005). Failure to find progressive temporal lobe volume decreases 10 years subsequent to a first episode of schizophrenia. Psychiatry Res. 138, 265-268. doi: 10.1016/j.pscychresns.2005.02.005
13. Dierks, T. Linden, D. E. Jandl, M. Formisano, E. Goebel, R. Lanfermann, H. et al. (1999). Activation of Heschl’s gyrus during auditory hallucinations. Neuron 22, 615-621. doi: 10.1016/S0896-6273(00)80715-1
14. Donato, R. (2001). S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668. doi: 10.1016/S1357-2725(01)00046-2
15. Douaud, G. Smith, S. Jenkinson, M. Behrens, T. Johansen-Berg, H. Vickers, J. et al. (2007). Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 130, 2375-2386. doi:10.1093/brain/awm184
16. Eldik, L. J. V. and Wainwright, M. S. (2003). The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor. Neurol. Neurosci. 21, 97-108.
17. Ellison-Wright, I. and Bullmore, E. (2009). Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr. Res. 108, 3-10. doi: 10.1016/j.schres.2008.11.021
18. Ellison-Wright, I. Glahn, D. C. Laird, A. R. Thelen, S. M. and Bullmore, E. (2008). The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am. J. Psychiatry 165, 1015-1023. doi: 10.1176/appi.ajp.2008.07101562
19. Gonçalves, C. A. Leite, M. C. and Guerra, M. C. (2010). Adipocytes as an important source of serum S100B and possible roles of this protein in adipose tissue. Cardiovasc. Psychiatry Neurol. 2010, 790431. doi: 10.1155/2010/790431
20. Gonçalves, C. A. Leite, M. C. and Nardin, P. (2008). Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin. Biochem. 41, 755-763. doi: 10.1016/j.clinbiochem.2008.04.003
21. Good, C. D. Johnsrude, I. S. Ashburner, J. Henson, R. N. Friston, K. J. and Frackowiak, R. S. (2001). A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14, 21-36. doi: 10.1006/nimg.2001.0786
22. Gupta, C. N. Calhoun, V. D. Rachakonda, S. Chen, J. Patel, V. Liu, J. et al. (2015). Patterns of gray matter abnormalities in schizophrenia based on an international mega-analysis. Schizophr. Bull. 41, 1133-1142. doi: 10.1093/schbul/sbu177
23. Hanson, D. R. and Gottesman, I. I. (2005). Theories of schizophrenia: a genetic- inflammatory-vascular synthesis. BMC Med. Genet. 6:7. doi: 10.1186/1471-2350-6-7
24. Harrison, P. J. (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(Pt 4), 593-624. doi: 10.1093/brain/122.4.593
25. Hercher, C. Chopra, V. and Beasley, C. L. (2014). Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder. J. Psychiatry Neurosci. 39, 376-385. doi: 10.1503/jpn.130277
26. Honea, R. Crow, T. J. Passingham, D. and Mackay, C. E. (2005). Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry 162, 2233-2245. doi: 10.1176/appi.ajp.162.12.2233
27. Kasai, K. Shenton, M. E. Salisbury, D. F. Hirayasu, Y. Lee, C. U. Ciszewski, A. A. et al. (2003b). Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am. J. Psychiatry 160, 156-164. doi: 10.1176/appi.ajp.160.1.156
28. Kasai, K. Shenton, M. E. Salisbury, D. F. Hirayasu, Y. Onitsuka, T. Spencer, M. H. et al. (2003a). Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 60, 766-775. doi: 10.1001/archpsyc.60.8.766
29. Katsel, P. Byne, W. Roussos, P. Tan, W. Siever, L. and Haroutunian, V. (2011). Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology 36, 1171-1177. doi: 10.1038/npp.2010.252
30. Konrad, A. and Winterer, G. (2008). Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophr. Bull. 34, 72-92. doi: 10.1093/schbul/sbm034
31. Kubicki, M. McCarley, R. Westin, C. F. Park, H. J. Maier, S. Kikinis, R. et al. (2007). A review of diffusion tensor imaging studies in schizophrenia. J. Psychiatr. Res. 41, 15-30. doi: 10.1016/j.jpsychires.2005.05.005
32. Kubicki, M. Park, H. Westin, C. F. Nestor, P. G. Mulkern, R. V. Maier, S. E. et al. (2005). DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage 26, 1109-1118. doi: 10.1016/j.neuroimage.2005.03.026
33. Kubicki, M. Westin, C. F. Nestor, P. G. Wible, C. G. Frumin, M. Maier, S. E. et al. (2003). Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study. Biol. Psychiatry 54, 1171-1180. doi: 10.1016/S0006-3223(03)00419-0
34. Kuroki, N. Kubicki, M. Nestor, P. G. Salisbury, D. F. Park, H. J. Levitt, J. J. et al. (2006). Fornix integrity and hippocampal volume in male schizophrenic patients. Biol. Psychiatry 60, 22-31. doi: 10.1016/j.biopsych.2005.09.021
35. Kyriakopoulos, M. and Frangou, S. (2009). Recent diffusion tensor imaging findings in early stages of schizophrenia. Curr. Opin. Psychiatry 22, 168-176. doi: 10.1097/YCO.0b013e328325aa23
36. Kyriakopoulos, M. Vyas, N. S. Barker, G. J. Chitnis, X. A. and Frangou, S. (2008). A diffusion tensor imaging study of white matter in early-onset schizophrenia. Biol. Psychiatry 63, 519-523. doi: 10.1016/j.biopsych.2007.05.021
37. Lieberman, J. A. Tollefson, G. D. Charles, C. Zipursky, R. Sharma, T. Kahn, R. S. et al. (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 62, 361-370. doi: 10.1001/archpsyc.62.4.361
38. Lipska, B. and Weinberger, D. (2002). A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus. Neurotox. Res. 4, 469-475. doi: 10.1080/1029842021000022089
39. Mitelman, S. A. Torosjan, Y. Newmark, R. E. Schneiderman, J. S. Chu, K. W. Brickman, A. M. et al. (2007). Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey. Schizophr. Res. 92, 211-224. doi: 10.1016/j.schres.2006.12.029
40. Monji, A. Kato, T. and Kanba, S. (2009). Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin. Neurosci. 63, 257-265. doi: 10.1111/j.1440-1819.2009.01945.x
41. Mori, S. Wakana, S. Nagae-Poetscher, L. M. and van Zijl, P. C. M. (2005). MRI Atlas of Human White Matter. Amsterdam: Elsevier.
42. Müller, N. and Schwarz, M. J. (2007). The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J. Neural. Transm. Suppl. 72, 269-280. doi:10.1007/978-3-211-73574-9_33
43. Nestor, P. G. Kubicki, M. Kuroki, N. Gurrera, R. J. Niznikiewicz, M. Shenton, M. E. et al. (2007). Episodic memory and neuroimaging of hippocampus and fornix in chronic schizophrenia. Psychiatry Res. 155, 21-28. doi: 10.1016/j.pscychresns.2006.12.020
44. Okugawa, G. Nobuhara, K. Minami, T. Takase, K. Sugimoto, T. Saito, Y. et al. (2006). Neural disorganization in the superior cerebellar peduncle and cognitive abnormality in patients with schizophrenia: a diffusion tensor imaging study. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 1408-1412. doi: 10.1016/j.pnpbp.2006.05.014
45. Pakkenberg, B. (1993). Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol. Psychiatry 34, 768-772. doi: 10.1016/0006-3223(93)90065-L
46. Pantelis, C. Velakoulis, D. McGorry, P. D. Wood, S. J. Suckling, J. Phillips, L. J. et al. (2003). Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361, 281-288. doi: 10.1016/S0140-6736(03)12323-9
47. Pantelis, C. Yücel, M. Wood, S. J. Velakoulis, D. Sun, D. Berger, G. et al. (2005). Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr. Bull. 31, 672-696. doi: 10.1093/schbul/sbi034
48. Pearlson, G. D. and Marsh, L. (1999). Structural brain imaging in schizophrenia: a selective review. Biol. Psychiatry 46, 627-649. doi: 10.1016/S0006-3223(99)00071-2
49. Pérez-Iglesias, R. Tordesillas-Gutiérrez, D. Barker, G. J. McGuire, P. K. Roiz- Santiañez, R. Mata, I. et al. (2010). White matter defects in first episode psychosis patients: a voxelwise analysis of diffusion tensor imaging. Neuroimage 49, 199-204. doi: 10.1016/j.neuroimage.2009.07.016
50. Peters, B. D. de Haan, L. Dekker, N. Blaas, J. Becker, H. E. Dingemans, P. M. et al. (2008). White matter fibertracking in first-episode schizophrenia, schizoaffective patients and subjects at ultra-high risk of psychosis. Neuropsychobiology 58, 19-28. doi: 10.1159/000154476
51. Pol, H. E. H. and Kahn, R. S. (2008). What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull. 34, 354-366. doi:10:1093/schbul/sbm168
52. Reiber, H. (2001). Dynamics of brain-derived proteins in cerebrospinal fluid. Clin. Chim. Acta 310, 173-186. doi: 10.1016/S0009-8981(01)00573-3
53. Rothermundt, M. Missler, U. Arolt, V. Peters, M. Leadbeater, J. Wiesmann, M. et al. (2001). Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol. Psychiatry 6, 445-449. doi: 10.1038/sj.mp.4000889
54. Rothermundt, M. Ponath, G. and Arolt, V. (2004a). S100B in schizophrenic psychosis. Int. Rev. Neurobiol. 59, 445-470. doi: 10.1016/S0074-7742(04)59017-7
55. Rothermundt, M. Ponath, G. Glaser, T. Hetzel, G. and Arolt, V. (2004b). S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia. Neuropsychopharmacology 29, 1004-1011. doi: 10.1038/sj.npp.1300403
56. Samartzis, L. Dima, D. Fusar-Poli, P. and Kyriakopoulos, M. (2014). White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies. J. Neuroimaging 24, 101-110. doi: 10.1111/j.1552-6569.2012.00779.x
57. Schroeter, M. L. Sacher, J. Steiner, J. Schoenknecht, P. and Mueller, K. (2013). Serum S100B represents a new biomarker for mood disorders. Curr. Drug Targets 14, 1237-1248. doi:10.2174/138945011131499 90014
58. Selemon, L. D. and Goldman-Rakic, P. S. (1999). The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45, 17-25. doi: 10.1016/S0006-3223(98)00281-9
59. Shergill, S. S. Kanaan, R. A. Chitnis, X. A. O’daly, O. Jones, D. K. Frangou, S. et al. (2007). A diffusion tensor imaging study of fasciculi in schizophrenia. Am. J. Psychiatry 164, 467-473. doi: 10.1176/appi.ajp.164.3.467
60. Sigmundsson, T. Suckling, J. Maier, M. Williams, S. Bullmore, E. Greenwood, K. et al. (2001). Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am. J. Psychiatry 158, 234-243. doi: 10.1176/appi.ajp.158.2.234
61. Smesny, S. Milleit, B. Nenadic, I. Preul, C. Kinder, D. Lasch, J. et al. (2010). Phospholipase A2 activity is associated with structural brain changes in schizophrenia. Neuroimage 52, 1314-1327. doi: 10.1016/j.neuroimage.2010.05.009
62. Steiner, J. Bernstein, H. G. Bielau, H. Berndt, A. Brisch, R. Mawrin, C. et al. (2007). Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci. 8:2. doi: 10.1186/1471-2202-8-2
63. Steiner, J. Bernstein, H. G. Bielau, H. Farkas, N. Winter, J. Dobrowolny, H. et al. (2008). S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J. Psychiatr. Res. 42, 868-876. doi: 10.1016/j.jpsychires.2007.10.001
64. Steiner, J. Schiltz, K. Walter, M. Wunderlich, M. T. Keilhoff, G. Brisch, R. et al. (2010a). S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research. Psychoneuroendocrinology 35, 321-324. doi: 10.1016/j.psyneuen.2009.07.012
65. Steiner, J. Walter, M. Guest, P. Myint, A. M. Schiltz, K. Panteli, B. et al. (2010b). Elevated S100B levels in schizophrenia are associated with insulin resistance. Mol. Psychiatry 15, 3-4. doi: 10.1038/mp.2009.87
66. Streitbuerger, D. P. Arelin, K. Kratzsch, J. Thiery, J. Steiner, J. Villringer, A. et al. (2012). Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study. PLoS ONE 7:e43284. doi: 10.1371/journal.pone.0043284
67. Suzuki, M. Nohara, S. Hagino, H. Kurokawa, K. Yotsutsuji, T. Kawasaki, Y. et al. (2002). Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr. Res. 55, 41-54. doi: 10.1016/S0920-9964(01)00224-9
68. Tramontina, F. Tramontina, A. C. Souza, D. F. Leite, M. C. Gottfried, C. Souza, D. O. et al. (2006). Glutamate uptake is stimulated by extracellular S100B in hippocampal astrocytes. Cell. Mol. Neurobiol. 26, 81-86. doi: 10.1007/s10571-006-9099-8
69. Walterfang, M. Wood, S. J. Velakoulis, D. Copolov, D. and Pantelis, C. (2005). Diseases of white matter and schizophrenia-like psychosis. Aust. N.Z. J. Psychiatry 39, 746-756. doi: 10.1080/j.1440-1614.2005.01678.x
70. Wang, F. Sun, Z. Du, X. Wang, X. Cong, Z. Zhang, H. et al. (2003). A diffusion tensor imaging study of middle and superior cerebellar peduncle in male patients with schizophrenia. Neurosci. Lett. 348, 135-138. doi:10.1016/S0304- 3940(03)00589-5
71. White, T. Nelson, M. and Lim, K. O. (2008). Diffusion tensor imaging in psychiatric disorders. Top. Magn. Reson. Imaging 19, 97-109. doi: 10.1097/RMR.0b013e3181809f1e
72. Wright, I. C. Rabe-Hesketh, S. Woodruff, P. W. David, A. S. Murray, R. M. and Bullmore, E. T. (2000). Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry 157, 16-25. doi: 10.1176/ajp.157.1.16